Avestar Capital’s Takeda Pharmaceutical TAK Stock Holding History

Avestar Capital’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-60,046	Closed	-$984K	–	500
2021 Q3	$984K	Buy	60,046 +4,691	+8%	+$78.8K	0.13%	186
2021 Q2	$932K	Buy	55,355 +23,881	+76%	+$407K	0.12%	194
2021 Q1	$528K	Buy	31,474 +15,838	+101%	+$285K	0.12%	178
2020 Q4	$285K	Buy	+15,636	New	+$274K	0.08%	222
2019 Q3	–	Sell	-2,088	Closed	-$35K	–	752
2019 Q2	$35K	Sell	2,088 -228	-10%	-$4.15K	0.02%	335
2019 Q1	$45K	Buy	2,316 +2,235	+2,759%	+$45K	0.03%	296
2018 Q4	$1K	Buy	+81	New	+$1.37K	﹤0.01%	772

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Avestar Capital's TAK Position: Q4 2021 in Review

Avestar Capital sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 60,046 shares — an estimated $984K sold.

Avestar Capital first reported a position in TAK in Q4 2018 and held it in 7 quarters. The position peaked at $984K in Q3 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Avestar Capital reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Avestar Capital sold 60,046 Takeda Pharmaceutical shares in Q4 2021, an estimated $984K.
Avestar Capital first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 7 quarters.
Avestar Capital's Takeda Pharmaceutical position peaked at $984K in Q3 2021.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Avestar Capital's 13F filing for Q4 2021, filed 1 Feb 2022.